Can your genes predict painkiller side effects after C-Section?

NCT ID NCT05380531

Recruiting now Knowledge-focused Sponsor: Senthil Sadhasivam Source: ClinicalTrials.gov ↗

First seen Jun 27, 2026 · Last updated Jun 27, 2026

Summary

This study aims to improve pain relief after cesarean sections by looking at how a mother's genes affect her response to opioids. Researchers will enroll 700 women and track genetic markers linked to side effects like breathing problems and nausea. The goal is to create a personalized pain management plan that reduces risks for both mothers and their breastfeeding infants.

This is an AI summary of the original study and may miss details. Read our disclaimer.

Get updates

Get notified about this study

Sign up to get updates when this study changes or when new studies for CESAREAN SECTION COMPLICATIONS are added.

Our safety recommendation!

By submitting, you agree to our Terms of use

Conditions

The condition(s) this trial relates to.

opioid abuse

As listed by the trial registrant

The condition terms exactly as the trial's registrant entered them.

CESAREAN SECTION COMPLICATIONS OPIOID USE

Contacts and locations

Locations

Riley Children's Hospital- Clinics / Labor and Delivery Unit
RECRUITING

Indianapolis, Indiana, 46202, United States
UPMC Magee Women's Hospital
NOT_YET_RECRUITING

Pittsburgh, Pennsylvania, 15213, United States
University of Pittsburgh
RECRUITING

Pittsburgh, Pennsylvania, 15260, United States
Washington University Hospital
RECRUITING

St Louis, Missouri, 63110, United States

More trials for these conditions

Other studies related to the condition(s) this trial covers.